IPC
AZN icon

Independent Portfolio Consultants’s AstraZeneca AZN Stock Holding History

Independent Portfolio Consultants’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$444K Sell
6,518
-2,350
-26% -$153K 0.18% 186
2017
Q1 		$552K Sell
8,868
-1,862
-17% -$108K 0.19% 189
2016
Q4 		$586K Sell
10,730
-630
-6% -$35.8K 0.19% 196
2016
Q3 		$738K Buy
11,360
+72
+0.6% +$4.71K 0.23% 150
2016
Q2 		$682K Sell
11,288
-717
-6% -$41.6K 0.21% 156
2016
Q1 		$676K Buy
12,005
+495
+4% +$29.7K 0.19% 162
2015
Q4 		$782K Sell
11,510
-375
-3% -$24.6K 0.23% 129
2015
Q3 		$756K Sell
11,885
-11,255
-49% -$740K 0.16% 172
2015
Q2 		$1.47M Buy
23,140
+20,830
+902% +$1.43M 0.29% 114
2015
Q1 		$158K Sell
2,310
-205
-8% -$14.2K 0.03% 401
2014
Q4 		$177K Sell
2,515
-3,275
-57% -$235K 0.04% 394
2014
Q3 		$414K Sell
5,790
-990
-15% -$72.5K 0.11% 284
2014
Q2 		$504K Sell
6,780
-500
-7% -$36.1K 0.14% 228
2014
Q1 		$472K Sell
7,280
-2,783
-28% -$180K 0.15% 246
2013
Q4 		$597K Sell
10,063
-605
-6% -$32.9K 0.21% 162
2013
Q3 		$554K Sell
10,668
-355
-3% -$17.8K 0.22% 170
2013
Q2 		$521K Buy
+11,023
New +$561K 0.23% 169

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Independent Portfolio Consultants's AZN Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its AstraZeneca (AZN) stake by 26% in Q2 2017, selling an estimated $153K and leaving 6,518 shares worth $444K. The position accounts for 0.18% of the portfolio, ranked #186.

Independent Portfolio Consultants first reported a position in AZN in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.47M in Q2 2015. 466 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

  • Independent Portfolio Consultants held 6,518 shares of AstraZeneca worth $444K as of Q2 2017.
  • Independent Portfolio Consultants sold 2,350 AstraZeneca shares in Q2 2017, an estimated $153K.
  • AstraZeneca made up 0.18% of Independent Portfolio Consultants's portfolio in Q2 2017, its #186 holding.
  • Independent Portfolio Consultants first reported a position in AstraZeneca in Q2 2013 and has held it in 17 quarters since.
  • Independent Portfolio Consultants's AstraZeneca position peaked at $1.47M in Q2 2015.
  • 466 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.